Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data LataMed AI Corp. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2024
FY2024
FY2025
Revenue
0
0
0
General and administrative
0.76
3.21
0.15
Operating expenses
0.83
3.3
0.17
Operating income
-0.83
-3.3
-0.17
Interest expense
0.03
0.04
0.04
Other non-operating income
-0.9
0.04
-0.04
Pre-tax income
-1.73
-3.26
-0.21
Income tax
0
0
0
Net income
-1.73
-3.26
-0.21
EPS, diluted
-0.02
-0.11
Shares, diluted (weighted)
88.9
29.3
Balance sheet
FY2024
FY2024
FY2025
Cash and equivalents
0
0
0
Total current assets
0
0
0
Total assets
0
0
0
Accounts payable
0.15
0.23
0.24
Total current liabilities
0.5
0.57
0.63
Total liabilities
0.5
0.57
0.63
Paid-in capital
25.6
28.8
28.9
Retained earnings
-26.1
-29.4
-29.6
Shareholders' equity
-0.5
-0.57
-0.63
Total equity
-0.5
-0.57
-0.63
Total liabilities and equity
0
0
0
Shares outstanding
0.26
29.3
44.3
Cash flow statement
FY2024
FY2024
FY2025
Net income
-1.73
-3.26
-0.21
Change in payables
0.06
0.1
0
Cash from operations
-0.07
-0.07
-0.21
Stock issued
0.15
Cash from financing
0.07
0.07
0.21
Net change in cash
0
0
0
Interest paid
0
0
0
Income taxes paid
0
0
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.43 on August 18, 2026.
Profitability
Metric
Value
How it is calculated
Return on equity (ROE)
-4.2%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-3.8%
Net income / average total assets.
Return on invested capital (ROIC)
-2.9%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.00x
Current assets / current liabilities.
Quick ratio
0.00x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.00x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.00
Revenue / diluted weighted shares.
Operating cash flow per share
-$0.01
Cash from operations / diluted weighted shares.
Book value per share
$0.20
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/B
2.20x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
2.20x
Market cap / tangible book value, when positive.
Earnings yield
-1.9%
Net income / market cap (the inverse of P/E).
What was LataMed AI Corp.'s revenue in fiscal 2025?
LataMed AI Corp. reported revenue of $0.0 for fiscal 2025.
Was LataMed AI Corp. profitable in fiscal 2025?
No. It reported a net loss of $207.5K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.